# TROKENDI XR
> **NDA201635** · New Drug Application · Sponsor: SUPERNUS PHARMS · Approved 2013-08-16
## Drug
- **FDA Application Number:** NDA201635
- **Application type:** New Drug Application
- **Brand name:** TROKENDI XR
- **Generic name:** TOPIRAMATE
- **Active ingredients:** TOPIRAMATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUPERNUS PHARMS
- **Manufacturer:** Supernus Pharmaceuticals, Inc.
- **First approval:** 2013-08-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201635)
---
*AI Analytics · CC0 1.0*